摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-acetyl-2-methyl-4-nitro-6-phenylpyridazin-3(2H)-one | 121918-49-8

中文名称
——
中文别名
——
英文名称
5-acetyl-2-methyl-4-nitro-6-phenylpyridazin-3(2H)-one
英文别名
5-acetyl-4-nitro-2-methyl-6-phenyl-3(2H)-pyridazinone;3(2H)-Pyridazinone, 5-acetyl-2-methyl-4-nitro-6-phenyl-;5-acetyl-2-methyl-4-nitro-6-phenylpyridazin-3-one
5-acetyl-2-methyl-4-nitro-6-phenylpyridazin-3(2H)-one化学式
CAS
121918-49-8
化学式
C13H11N3O4
mdl
——
分子量
273.248
InChiKey
SEUVWDIFXJQCNB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    95.6
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:0a468d5e0af389ae3305baed7dddfc64
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

点击查看最新优质反应信息

文献信息

  • 4-Amino-5-substituted-3(2<i>H</i>)-pyridazinones as Orally Active Antinociceptive Agents:  Synthesis and Studies on the Mechanism of Action
    作者:Maria Paola Giovannoni、Nicoletta Cesari、Claudia Vergelli、Alessia Graziano、Claudio Biancalani、Pierfrancesco Biagini、Carla Ghelardini、Elisa Vivoli、Vittorio Dal Piaz
    DOI:10.1021/jm070161e
    日期:2007.8.1
    doses of 3-20 mg kg-1 po, showed good antinociceptive activity, reducing by more than 50% the number of writhes with respect to controls. Compounds 16c, 19a, 20a, and 28 were the most potent of the series because they were able to induce a potent antinociceptive effect at a dose of 3 mg kg-1 po. None of the active compounds at the analgesic dose provoked any visible change in normal behavior, as demonstrated
    合成了许多4-氨基-5-乙烯基吡啶酮酮和4-氨基-5-杂环吡啶酮酮,并测试了它们的镇痛活性。以3-20 mg kg-1 po的剂量测试的许多这些化合物均显示出良好的抗伤害感受活性,相对于对照而言,减少了超过50%的扭伤次数。化合物16c,19a,20a和28是该系列中最有效的化合物,因为它们能够以3 mg kg-1 po的剂量诱导有效的镇痛作用。如旋转仪测试所示,在镇痛剂量下,没有一种活性化合物引起正常行为的任何可见变化。作用机理的研究表明,用α2-拮抗剂育亨宾预处理可以完全阻止由活性化合物引起的镇痛作用,这表明α2-肾上腺素能受体的参与。
  • 5-Acetyl-2-methyl-4-nitro-6-phenyl-3(2<i>H</i>)-pyridazinone: Versatile Precursor to Hetero-Condensed Pyridazinones
    作者:V. Dal Piaz、G. Ciciani、M. P. Giovannoni
    DOI:10.1055/s-1994-25540
    日期:——
    The title compound 2 was found to be a very useful intermediate to synthesize five- and six-membered hetero-condensed pyridazinones in high yields under generally mild and simple reaction conditions.
    研究发现,标题化合物 2 是一种非常有用的中间体,可在温和简单的反应条件下高产率合成五元和六元杂缩合哒嗪酮。
  • 5-Acyl-6-aryl-4-nitro-3(2H)pyridazinones and Related 4-Amino Compounds: Synthesis and Pharmacological Evaluation
    作者:Vittorio Dal Piaz、Giovanna Ciciani、Giovanni Turco、Maria Paola Giovannoni、Mauro Miceli、Renato Pirisino、Mauro Perretti
    DOI:10.1002/jps.2600800412
    日期:1991.4
    Several 4-nitro- and 4-amino-5-acyl-6-aryl-3(2H)pyridazinones were prepared and their in vitro and ex vivo antiaggregatory properties were evaluated. 4-Nitro derivatives 3 generally showed good activity in vitro towards arachidonic acid (AA)-induced human blood platelet aggregation. The 4-amino compound 4a, which has weak in vitro activity, exhibited antiplatelet activity, particularly on adenosine
    制备了几种4-硝基-和4-氨基-5-酰基-6-芳基-3(2H)哒嗪酮,并评估了它们的体外和离体抗聚集特性。4-硝基衍生物3通常在体外对花生四烯酸(AA)诱导的人类血小板聚集具有良好的活性。体外活性较弱的4-氨基化合物4a表现出抗血小板活性,尤其是对兔体内脱磷酸腺苷(ADP)诱导的聚集具有抑制作用。此外,显示出相同的化合物在血小板活化因子(PAF)诱导的大鼠爪痛觉过敏中具有活性,并具有较低的急性口服毒性。还发现口服给予大鼠的4-氨基衍生物4a-m和其他哒嗪酮5-9比乙酰水杨酸(ASA)更有效。化合物3a和4a 在脂多糖(LPS)刺激的大鼠腹膜巨噬细胞上进行了体外试验,结果显示该药物在抑制前列腺素E2(PGE2)的产生和白介素1活性方面具有活性。在一系列抗聚集的哒嗪酮3中的结构活性关系研究表明,分别在位置4和5处的硝基和乙酰基取代基至关重要。为了更好的活性,还需要位置2的疏水取代基。
  • Phenylpiperazinylalkylamino Substituted Pyridazinones as Potent α<sub>1</sub> Adrenoceptor Antagonists
    作者:Daniela Barlocco、Giorgio Cignarella、Vittorio Dal Piaz、M. Paola Giovannoni、Pier G. De Benedetti、Francesca Fanelli、Federica Montesano、Elena Poggesi、Amedeo Leonardi
    DOI:10.1021/jm0009336
    日期:2001.7.1
    QSAR models have been used for designing a series of compounds characterized by a N-phenylpiperazinylalkylamino moiety linked to substituted pyridazinones, which have been synthesized. Measurements of the binding affinities of the new compounds toward the alpha (1a)-, alpha (1b)-, and alpha (1d)-AR cloned subtypes as well as the 5-HT1A receptor have been done validating, at least in part, the estimations of the theoretical models. This study provides insight into the structure activity relationships of the alpha (1)-ARs ligands and their alpha (1)-AR/5-HT1A selectivity.
  • Piaz, Vittorio Dal; Giovannoni, Maria Paola; Ciciani, Giovanna, Synlett, 1999, # 9, p. 1453 - 1455
    作者:Piaz, Vittorio Dal、Giovannoni, Maria Paola、Ciciani, Giovanna、Vergelli, Claudia
    DOI:——
    日期:——
查看更多